Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms

被引：17

作者：

Dursun, SM ^{[1
]}

Devarajan, S ^{[1
]}

机构：

[1] Dalhousie Univ, Dept Psychiat, Psychopharmacol Res Unit, Halifax, NS B3H 2E2, Canada

来源：

PSYCHOPHARMACOLOGY | 2001年 / 153卷 / 04期

关键词：

D O I：

10.1007/s002130000579

中图分类号：

Q189 [神经科学];

学科分类号：

071006 [神经生物学];

摘要：

引用

页码：497 / 498

页数：2

共 7 条

[1]

*CAN NETW MOOD ANX, 1999, GUID DIAGN PHARM TRE

[2]

CHEHIL S, 2000, IN PRESS CAN FAM PHY

[3]

COWEN PJ, 1998, ADV PSYCHIAT TREAT, V4, P320

[4]

Devarajan S, 2000, CAN J PSYCHIAT, V45, P489

[5]

Treatment-resistant depression: Progress and limitations [J].

O'Reardon, JP ;

Amsterdam, JD .

PSYCHIATRIC ANNALS, 1998, 28 (11) :633-+

[6]

Treatment resistant depression: methodological overview and operational criteria [J].

Souery, D ;

Amsterdam, J ;

de Montigny, C ;

Lecrubier, Y ;

Montgomery, S ;

Lipp, O ;

Racagni, G ;

Zohar, J ;

Mendlewicz, J .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1999, 9 (1-2) :83-91

[7]

Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine [J].

Whale, R ;

Quested, DJ ;

Laver, D ;

Harrison, PJ ;

Cowen, PJ .

PSYCHOPHARMACOLOGY, 2000, 150 (01) :120-122

← 1 →